VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Vireo Growth Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026
- Market cap
- $406.23M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.48 (−56.03%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Vireo Growth Inc. grew revenue 316.7% to $511.67M over the twelve months to Jun 30, 2026. Operating income fell 43.7% to $1.69M, moving the operating margin from 2.5% to 0.3%. Free cash flow was -$116.31M.
Revenue
$511.67M
+316.7% vs. a year earlier
Operating income
$1.69M
-43.7% vs. a year earlier
Free cash flow
-$116.31M
TTM Q2 2026
EPS, diluted
-$2.08
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $406.23M
- P/E ratio
- –
- Price to sales
- 0.79
- Price to book
- 0.92
- Dividend yield
- –
- Free cash flow yield
- -28.63%
Fundamentals
- Revenue
- $511.67M
- Net income
- -$67.07M
- EPS, diluted
- -$2.08
- Free cash flow
- -$116.31M
- Book value per share
- $9.81
- Diluted shares
- 45M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$511.67M+316.7% YoY
Gross profit
$248.87M+330.7% YoY
Operating income
$1.69M-43.7% YoY
Net income
-$67.07M
EPS, diluted
-$2.08
Free cash flow
-$116.31M
Reported periodTrailing twelve months